Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.45836
Abstract: Key Points Questions What is the incidence rate of germline alterations in CDH1, which has been reported as a susceptibility gene present in 25% to 50% of patients with hereditary diffuse gastric cancer (HDGC), and… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51733
Abstract: Oculopharyngeal muscular dystrophy (OPMD) is a late‐onset inherited neuromuscular disorder, with progressive ptosis and dysphagia as common manifestations. To date, OPMD has rarely been reported among East Asians. The present study summarizes the phenotypic and… read more here.
Sign Up to like & get recommendations! 2
Published in 2021 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.29653
Abstract: We aimed to explore the impact of 7‐Fr sheaths on the incidence of early radial artery occlusion (RAO) after transradial coronary intervention (TRI) in Chinese patients. read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Clinical Cardiology"
DOI: 10.1002/clc.22649
Abstract: Little is known about the comparative effectiveness and safety of non–vitamin K antagonist oral anticoagulants (NOAC) compared to warfarin in Chinese atrial fibrillation (AF) patients. Our aim was to compare the ischemic stroke risk reduction… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Clinical Cardiology"
DOI: 10.1002/clc.23939
Abstract: Leadless pacemakers are widely used, but the quality of life assessment of patients with leadless pacemakers is still unclear. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "International Journal of Cancer"
DOI: 10.1002/ijc.34296
Abstract: First‐line chemotherapy for advanced/metastatic human epidermal growth factor receptor 2 (HER2)‐negative gastric/gastroesophageal junction cancer (GC/GEJC) has poor median overall survival (OS; read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "International Journal of Cancer"
DOI: 10.1002/ijc.34424
Abstract: Refractory or relapsing metastatic triple‐negative breast cancer (mTNBC) has a poor prognosis. Sacituzumab govitecan (SG) is a novel antibody‐drug conjugate, targeting human trophoblast cell‐surface antigen 2 (Trop‐2). This is the first report of SG's efficacy… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Clinical Pharmacology"
DOI: 10.1002/jcph.1432
Abstract: Nivolumab is the first anti–programmed death‐1 agent approved in China for treatment of locally advanced or metastatic non–small cell lung cancer (NSCLC). Here, we characterize the population pharmacokinetics (PPK) of nivolumab monotherapy in Chinese patients… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.24704
Abstract: To develop and validate a nomogram to estimate the pretest probability of malignancy in Chinese patients with solid solitary pulmonary nodule (SPN). read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Molecular Genetics & Genomic Medicine"
DOI: 10.1002/mgg3.1316
Abstract: Abstract Background Sialidosis type 1 is a rare inherited disorder with a high disability. No genetically confirmed mainland Chinese patient with sialidosis type 1 has been reported. This study evaluated the phenotypes and genotypes of… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Nursing Open"
DOI: 10.1002/nop2.1283
Abstract: The purpose of this study was to explore the relationship among kinesiophobia, self‐efficacy and self‐management behaviour related to physical activity (SMBPA) in Chinese patients with coronary heart disease(CHD) and the mediating role of self‐efficacy between… read more here.